OriGene Antibodies in recent publications
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
|View All Citations >>||
Home All anti-MYC antibodies
|Homo sapiens v-myc myelocytomatosis viral oncogene homolog (avian) (MYC)|
|bHLHe39; c-Myc; MRTL|
|Synthetic peptide contain a sequence corresponding to a region within amino acids 1 and 27 of c-Myc|
|0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.|
|WB, IF, FC
EGFR1 Signaling Pathway
Jak-STAT signaling pathway
MAPK signaling pathway
TGF Beta Signaling Pathway
Wnt Signaling Pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
A: human ESC (anti-MYC antibody diluted at 1:1000)
A: mouse ESC (anti-MYC antibody diluted at 1:3000)
Immunofluorescence analysis of paraformaldehyde-fixed HeLa, using c-Myc(anti-MYC antibody) antibody at 1:200 dilution.
Flow cytometry on human embryonic stem cells, staining with c-Myc (anti-MYC antibody)antibody at 1:100 dilution(purple) or rabbit IgG (black).